AG001U74

163521-08-2 | 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)

Chemical structure of 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1), CAS 163521-08-2
AG001U74
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 163521-08-2
Catalog Number AG001U74(AGN-PC-0LVEVQ)
Chemical Name 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)
IUPAC Name 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride
InChI InChI=1S/C26H27N5O2.ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32;/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32);1H
InChI Key RPZBRGFNBNQSOP-UHFFFAOYSA-N
MDL Number MFCD00940014
Molecular Formula C26H28ClN5O2
Molecular Weight 477.9858
SMILES Cl.C(#N)C=1C=C2C(=CNC2=CC1)CCCCN1CCN(CC1)C=1C=CC2=C(C=C(O2)C(=O)N)C1
UNII U8HTX2GK8J
Synonyms
2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1), 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide, 68843, EMD, EMB 68843, EMB-68843, EMB68843, EMD 68843, HCl, Vilazodone, Hydrochloride, Vilazodone, Viibryd, vilazodone, Vilazodone HCl, vilazodone hydrochloride, Vilazodone hydrochloride, 163521-08-2, Vilazodone HCl, Viibryd, UNII-U8HTX2GK8J, Vilazodone (Hydrochloride), EMD 68843, U8HTX2GK8J, Vilazodone hydrochloride [USAN], CHEBI:70705, SB659746A, 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide hydrochloride, 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride, EMD 68 843, SB 659746A, SB-659746A, AK161007, EMD-68843, Vilazodone hydrochloride (USAN), 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride, EMD-68-843, SB-659746-A, Vilazodonei, vilazodone-hcl, 2-Benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1), 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1), 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide hydrochloride, 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide hydrochloride, Viibryd (TN), AC1OCFA0, vilazodone monohydrochloride, C26H27N5O2.ClH, SCHEMBL867358, CHEMBL1615374, KS-00000SKE, RPZBRGFNBNQSOP-UHFFFAOYSA-N, BCP11496, EMD68843, 2794AH, MFCD00940014, s4259, AKOS024464039, AN-5344, API0009252, CCG-213313, CS-0549, EBD2199528, RL02096, RL02097, SB659746-A, AC-25885, HY-14261, LS-34922, Vilazodone hydrochloride, >=98% (HPLC), AB0000947, AX8294006, A3919, ST24050347, SW219887-1, D09699, 521V128, J-525160, 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride, 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)piperazine hydrochloride, 1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride, 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2carboxamide hydrochloride, 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxamide hydrochloride, 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride, 4-(2-carbamoyl-1-benzofuran-5-yl)-1-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-ium chloride, 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide monohydrochloride, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride, Vilazodone hydrochloride solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Vilazodone, CID6918313, CS-O-15479, V0149, 163521-08-2 (HCl), 163521-12-8, Vilazodone hydrochloride, 98%, a 5-HT1A receptor partial agonist - 250MG 250mg,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited